Sanofi to slash $12bn stake in biotech Regeneron
CEO Paul Hudson says proceeds will go to scientific research and potentially acquisitions
Full Article
Sanofi to slash $12bn stake in biotech Regeneron
FT.com
0 shares
1 views
You might like
Related news coverage
Sanofi to slash $12bn stake in US biotech Regeneron
CEO Paul Hudson says proceeds will go to scientific research and potentially acquisitions
FT.com